The expression of LAT1 is important for BPA uptake, and BPA-based BNCT may be used for the treatment of squamous cell carcinoma and transitional epithelial carcinoma via the enhanced expression of LAT1. The gene discussed is SLC7A5; the disease is squamous cell carcinoma.